Literature DB >> 12167183

Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Tufan Tükek1, Pinar Yildiz, Vakur Akkaya, Mehmet Akif Karan, Dursun Atilgan, Veysel Yilmaz, Ferruh Korkut.   

Abstract

BACKGROUND: Supraventricular tachyarrhythmia is a common problem in chronic obstructive pulmonary disease (COPD) patients. The purpose of this study is to analyze the factors associated with paroxysmal atrial fibrillation (AF) in COPD patients.
METHODS: Forty COPD patients (38 male, 2 female, mean age 60 +/- 9 years) and 33 healthy controls (29 male, 4 female, mean age: 58 +/- 10 years) were included in this study. Echocardiography, 24-hour ambulatory and 12-lead ECG, pulmonary function tests, arterial blood gases, and serum electrolytes were measured. On ECG, maximum (P(max)) and minimum (P(min)) duration of P wave and its difference, P-wave dispersion (PWd), were measured.
RESULTS: On echocardiography, diastolic dysfunction was found in 14 of the 40 (35%) COPD patients. Heart rate variability analysis revealed that COPD patients had decreased SDANN, SDNN, SDNNIDX in time-domain, and decreased LF in frequency domain parameters. Fourteen of the 40 COPD patients (35%) had AF. Patients with AF were older (57 +/- 10 vs 64 +/- 5 years, P = 0.03) and had lower SDANN, SDNN, and LF/HF ratio as compared to patients without AF in univariate analysis. All P-wave intervals (P(max), P(min,) and PWd) were increased in COPD patients compared to controls. P-wave dispersion was significantly increased in COPD patients with AF, as compared to patients without AF (57 +/- 11 vs 44 +/- 7 ms, P = 0.001). In logistic regression analysis PWd was found to be the only factor associated with the development of AF (P = 0.04).
CONCLUSIONS: The presence of AF was significantly related to the prolongation of PWd, but not with pulmonary function, arterial blood gasses, and left and right atrial function.

Entities:  

Mesh:

Year:  2002        PMID: 12167183      PMCID: PMC7027775          DOI: 10.1111/j.1542-474x.2002.tb00167.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  27 in total

1.  P-WAVE ANALYSIS IN VALVULAR HEART DISEASE.

Authors:  J J MORRIS; E H ESTES; R E WHALEN; H K THOMPSON; H D MCINTOSH
Journal:  Circulation       Date:  1964-02       Impact factor: 29.690

2.  P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation.

Authors:  N Ozer; K Aytemir; E Atalar; E Sade; S Aksöyek; K Ovünç; T Açýl; N Nazlý; F Ozmen; A Oto; S Kes
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

3.  Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency.

Authors:  P K Stein; P Nelson; J N Rottman; D Howard; S M Ward; R E Kleiger; R M Senior
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

4.  Right and left ventricular dysfunction in patients with severe pulmonary disease.

Authors:  C D Vizza; J P Lynch; L L Ochoa; G Richardson; E P Trulock
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

Review 5.  Arrhythmias in patients with chronic obstructive pulmonary disease.

Authors:  R E Brashear
Journal:  Med Clin North Am       Date:  1984-07       Impact factor: 5.456

6.  Two-dimensional echocardiographic assessment of left ventricular function in chronic obstructive pulmonary disease.

Authors:  F Jardin; P Gueret; J F Prost; J C Farcot; Y Ozier; J P Bourdarias
Journal:  Am Rev Respir Dis       Date:  1984-01

7.  Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease.

Authors:  R A Incalzi; R Pistelli; L Fuso; A Cocchi; M G Bonetti; A Giordano
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

Review 8.  Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease.

Authors:  R B Devereux; M J Koren; G de Simone; P M Okin; P Kligfield
Journal:  Eur Heart J       Date:  1993-07       Impact factor: 29.983

9.  Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease.

Authors:  H T Shih; C R Webb; W A Conway; E Peterson; B Tilley; S Goldstein
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

10.  Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria.

Authors:  A D Waggoner; A V Adyanthaya; M A Quinones; J K Alexander
Journal:  Circulation       Date:  1976-10       Impact factor: 29.690

View more
  23 in total

1.  Effect of obesity on p-wave parameters in a Chinese population.

Authors:  Tong Liu; Zili Fu; Panagiotis Korantzopoulos; Xiaowei Zhang; Shaohua Wang; Guangping Li
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

2.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

3.  Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion.

Authors:  Yuhi Fujimoto; Kenji Yodogawa; Kenta Takahashi; Ippei Tsuboi; Hiroshi Hayashi; Shunsuke Uetake; Yu-Ki Iwasaki; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

4.  Heart rate variability and procedural outcome in catheter ablation for atrial fibrillation.

Authors:  Geoffrey E J Seaborn; Keith Todd; Kevin A Michael; Adrian Baranchuk; Hoshiar Abdollah; Christopher S Simpson; Selim G Akl; Damian P Redfearn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09-24       Impact factor: 1.468

5.  Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Authors:  James E Tisdale; Matthew R Allen; Brian R Overholser; Heather A Jaynes; Richard J Kovacs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-03-31

6.  Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease.

Authors:  Ilker Murat Caglar; Tolga Dasli; Fatma Nihan Turhan Caglar; Mehmet Kamil Teber; Murat Ugurlucan; Gokhan Ozmen
Journal:  Clin Res Cardiol       Date:  2012-03-06       Impact factor: 5.460

7.  P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).

Authors:  Jared W Magnani; Michael J Mazzini; Lisa M Sullivan; MaryAnn Williamson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

Review 8.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31

9.  Predictors of early recurrence and delayed cure after segmental pulmonary vein isolation for paroxysmal atrial fibrillation without structural heart disease.

Authors:  Hong Jiang; Zhibing Lu; Handong Lei; Dongdong Zhao; Bo Yang; Congxin Huang
Journal:  J Interv Card Electrophysiol       Date:  2006-09-06       Impact factor: 1.900

10.  Increased P wave dispersion and maximum P wave duration after hemodialysis.

Authors:  Ugur K Tezcan; Basri Amasyali; Ilknur Can; Kudret Aytemir; Sedat Köse; Izzet Yavuz; Hurkan Kursaklioglu; Ersoy Işik; Ertan Demirtaş; Ali Oto
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.